Cornel Chiriac

Cornel is the founding partner of 2050 Capital and focuses on the UK/EU market. Among other deals, Cornel led the seed investment rounds in Hadean (distributed HPC), AMFG (digital factory software), Vaticle (knowledge graph type db and query language), and Origin Sciences (DNA sequencing cancer diagnostics). Cornel serves on several boards and advisory committees.

Complementary to 2050 Capital, Cornel heads the Chicago Booth Angels London chapter, was instrumental to scaling the investment group globally, and is involved with various University of Chicago venture initiatives.

In his earlier career Cornel built and scaled two ventures in the USA to multi-million exits, was a strategy and deal consultant with L.E.K. in London, and a corporate VC with the World Gold Council. Cornel also worked on energy transition engagements with Fieldstone Capital. Prior to settling in London, Cornel lived and worked in the USA for over a decade and in China & South-East Asia for four years. Cornel holds a MBA from the University of Chicago Booth School of Business.